Coronavirus (COVID-19)

  • Your Selections:

Refine Results

date

Topics

Content Type

Tags

COVID-19 Coronavirus Tracker – Updated as of May 6

This tracker provides the number of cases and deaths from novel coronavirus by country, the trend in case and death counts by country, and a global map of showing which countries have cases and deaths. There have been over 7.2 million confirmed cases and 411,000 confirmed deaths worldwide. There have been nearly 2 million confirmed cases and 112,000 confirmed deaths in the United States.

KFF COVID-19 Vaccine Monitor – April 2021

Most adults nationally say they have gotten at least one dose of a COVID-19 vaccine, and few say they haven’t but want to do so right away, posing a new challenge for the nation’s vaccination efforts. The latest report also explores parents’ intentions for their kids, confidence in vaccines’ safety, and a variety of potential incentives and requirements to increase vaccination uptake.

State COVID-19 Data and Policy Actions

Explore state-level data on a variety of COVID-19 metrics, including the latest hotspots, cases and deaths by race and ethnicity and at long-term care facilities. Find up-to-date information on state policy actions on social distancing measures and reducing barriers to COVID-19 testing and treatment.

Which States are Hitting the COVID-19 Vaccine Tipping Point?

As of April 19, COVID-19 vaccine eligibility opened up to adults in all states, leaving many to wonder when supply will surpass vaccine demand. A recent brief examined when COVID-19 vaccine supply might outstrip demand in the U.S. nationally, estimating that the U.S. will reach this point within a few…

Supply vs Demand: Which States are Reaching their COVID-19 Vaccine Tipping Points?

This analysis examines overall COVID-19 vaccination levels and how the rate of vaccinations over the last week has changed at state-level and national level. There is significant variability by state in how many adults in the US have been vaccinated with at least one dose. Most states are also seeing a decline in the pace of vaccinations, indicating that they may be approaching the point when vaccine supply exceeds demand.

What Could the U.S. Do to Help Improve Global COVID-19 Vaccine Equity?

As India and other countries continue to grapple with major COVID-19 outbreaks even as cases decline in this country, there is increasing attention to the global role that could be played by the U.S. government.  This is particularly the case now that the U.S. will soon have enough COVID-19 vaccine…

Global COVID-19 Vaccine Equity: U.S. Policy Options and Actions to Date

This brief examines U.S. policy options for helping expand global access to COVID-19 vaccines, focusing on four main areas: in-kind donations of vaccine doses, additional funding for global access mechanisms like COVAX, helping expand global vaccine manufacturing, and relaxing or waiving intellectual property protections on vaccine technologies. We summarize what the administration has done to date in these areas and policy issues related to each.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.